Edition:
United States

Ablynx NV (ABLX.BR)

ABLX.BR on Brussels Stock Exchange

12.40EUR
11:35am EDT
Change (% chg)

€0.23 (+1.89%)
Prev Close
€12.17
Open
€12.14
Day's High
€12.46
Day's Low
€12.05
Volume
221,015
Avg. Vol
101,006
52-wk High
€13.20
52-wk Low
€8.21

Latest Key Developments (Source: Significant Developments)

Van Herk Investments announces 10.07 pct shareholding in Ablynx
Tuesday, 24 Jan 2017 01:00am EST 

Ablynx Nv :Van Herk Investments B.V. announces 10.07 pct shareholding in Ablynx, an increase from a former position of 5.40 pct (August 2016).  Full Article

Ablynx achieves first milestone in collaboration with Novo Nordisk
Wednesday, 30 Nov 2016 01:00am EST 

Ablynx NV : Ablynx achieves first milestone as part of collaboration with Novo Nordisk . Ablynx to receive 1 million euro ($1.06 million) success fee . Ablynx received an upfront license fee of 5 million euros and will receive up to 4 million euros in research funding during the initial three year research term of the collaboration .Ablynx is eligible to receive potential development, regulatory and commercial milestone payments of up to 182 million euros plus tiered royalties on the annual net sales.  Full Article

FMR LLC announces 9.10 pct shareholding in Ablynx
Friday, 18 Nov 2016 01:00am EST 

Ablynx NV :FMR LLC announces 9.10 pct shareholding in Ablynx.  Full Article

Ablynx H1 net income turns to profit of 22.8 million euros
Thursday, 25 Aug 2016 01:00am EDT 

Ablynx NV : H1 total revenues were 53.5 million euros ($60.3 million), a 39 pct increase compared with 2015 . H1 operating loss reduced to 2.0 million euros, compared with 7.4 million euros in 2015 . H1 net profit of 22.8 million euros versus loss of 15.2 million euros year ago .Outlook for remainder of year confirmed.  Full Article

Bank of America Corporation announce 5.24 pct shareholding in Ablynx
Thursday, 4 Aug 2016 01:00am EDT 

Ablynx NV :Bank of America Corporation announce 5.24 pct shareholding in Ablynx.  Full Article

Ablynx CEO sees potential multibillion-dollar opportunity for drug
Thursday, 7 Jul 2016 04:22am EDT 

Ablynx CEO Edwin Moses told Reuters: Sales opportunity for vobarilizumab could be in "billions" of dollars in rheumatoid arthritis & other diseases . AbbVie will decide later in 2016 whether to license vobarilizumab, after second RA trial results expected in August Further company coverage: [ABLX.BR] (Reporting by UK bureau) ((uk.online@reuters.com;)).  Full Article

Vectura says Ablynx to exercise a license option on Fox device
Tuesday, 28 Jun 2016 04:57am EDT 

Vectura Group Plc :Ablynx to exercise option to license Vectura's Fox device for use in its forthcoming phase IIB efficacy study of its inhaled anti-rsv nanobody.  Full Article

Van Herk Investments announce 3.02 pct shareholding in Ablynx
Thursday, 16 Jun 2016 01:00am EDT 

Ablynx NV :Van Herk Investments announce 3.02 pct shareholding in Ablynx.  Full Article

Ablynx successfully raises 74.2 mln euros
Thursday, 2 Jun 2016 03:17am EDT 

Ablynx NV : Announced on Wednesday that it has raised 74.2 million euros ($83.1 million) through a private placement of new shares via an accelerated book building procedure announced on June 1, 2016 .Has placed 5,533,720 new shares with domestic and international institutional investors at a price of 13.40 euros per share, i.e. a 6.29 pct discount to June 1 closing price.  Full Article

Ablynx to raise capital through private placement of new shares
Wednesday, 1 Jun 2016 11:42am EDT 

Ablynx Nv : To raise capital through a private placement of new shares . To raise gross proceeds of up to approximately 60 million euro ($67.0 million) .J.P. MORGAN Securities Plc, Jefferies International Limited and KBC Securities are acting as joint bookrunners.  Full Article

BRIEF-Ablynx announces warrant exercise

* AS A RESULT OF THIS TRANSACTION, ABLYNX NOW HAS 61,169,732 SHARES OUTSTANDING